Literature DB >> 31978011

The Epidemiology and Etiology of Cholangitis After Kasai Portoenterostomy in Patients With Biliary Atresia.

Seung Hwan Baek1, Ji-Man Kang1, Kyong Ihn2, Seok Joo Han2, Hong Koh1, Jong Gyun Ahn1.   

Abstract

OBJECTIVES: We investigated the incidence and characteristics of cholangitis after Kasai portoenterostomy (KPE) in patients with biliary atresia. We also examined the distribution and antimicrobial susceptibility patterns of the causative pathogens, which were isolated in sterile specimens, such as blood and ascites.
METHODS: A retrospective chart review was performed in patients with biliary atresia who underwent KPE at Severance Children's Hospital in Korea from 2006 to 2015. The Kaplan-Meier method was used to assess the cumulative incidence of cholangitis.
RESULTS: Among the 160 included patients, there were 494 episodes of cholangitis in 126 patients (78.8%) during the study period. The cumulative incidence of cholangitis at 1 and 5 years after KPE was 75.5% and 84.2%, respectively, and cholangitis recurred in most cases (76.2%). The cumulative incidence of culture-proven cholangitis at 1 and 5 years after KPE was 22.1% and 23.9%, respectively. Enterococcus faecium (27.7%) was the most prevalent pathogen, followed by Escherichia coli (14.9%), Enterobacter cloacae (10.6%), and Klebsiella pneumoniae (8.5%). Gram-positive isolates (n = 19) showed low susceptibility to ampicillin (42.1%) and gentamicin (66.7%), and only 38.1% of Gram-negative isolates (n = 21) were susceptible to cefotaxime.
CONCLUSIONS: The present study is the largest to show the high incidence and characteristics of cholangitis after KPE in patients with biliary atresia. Enterococcus is a common pathogen of cholangitis after KPE and should be considered when choosing empiric antimicrobial therapy.

Entities:  

Mesh:

Year:  2020        PMID: 31978011     DOI: 10.1097/MPG.0000000000002555

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Study protocol of Phase 2 open-label multicenter randomized controlled trial for granulocyte-colony stimulating factor (GCSF) in post-Kasai Type 3 biliary atresia.

Authors:  Hoa Pham Anh Nguyen; Jinma Ren; Marilyn Butler; Henri Li; Saqib Qazi; Kamran Sadiq; Hieu Trung Dao; AiXuan Holterman
Journal:  Pediatr Surg Int       Date:  2022-04-07       Impact factor: 1.827

Review 2.  Biliary Atresia in Children: Update on Disease Mechanism, Therapies, and Patient Outcomes.

Authors:  Swati Antala; Sarah A Taylor
Journal:  Clin Liver Dis       Date:  2022-06-25       Impact factor: 6.265

3.  Impact of Two Antibiotic Therapies on Clinical Outcome and Gut Microbiota Profile in Liver Transplant Paediatric Candidates Colonized by Carbapenem-Resistant Klebsiella pneumoniae CR-KP.

Authors:  Sabrina Cardile; Federica Del Chierico; Manila Candusso; Sofia Reddel; Paola Bernaschi; Andrea Pietrobattista; Marco Spada; Giuliano Torre; Lorenza Putignani
Journal:  Front Cell Infect Microbiol       Date:  2021-12-14       Impact factor: 5.293

4.  Cholangitis Definition and Treatment after Kasai Hepatoportoenterostomy for Biliary Atresia: A Delphi Process and International Expert Panel.

Authors:  Ana M Calinescu; Omid Madadi-Sanjani; Cara Mack; Richard A Schreiber; Riccardo Superina; Deirdre Kelly; Claus Petersen; Barbara E Wildhaber
Journal:  J Clin Med       Date:  2022-01-19       Impact factor: 4.241

5.  Analysis of Cholangitis Rates with Extended Perioperative Antibiotics and Adjuvant Corticosteroids in Biliary Atresia.

Authors:  Lynette Goh; Kong Boo Phua; Yee Low; Li Wei Chiang; Chen Yong; Fang Kuan Chiou
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2021-07-05

6.  Long-Term Effects of Kasai Portoenterostomy for Biliary Atresia Treatment in Russia.

Authors:  Anna Degtyareva; Alexander Razumovskiy; Nadezhda Kulikova; Sergey Ratnikov; Elena Filippova; Ekaterina Gordeeva; Marina Albegova; Denis Rebrikov; Anna Puchkova
Journal:  Diagnostics (Basel)       Date:  2020-09-11

7.  Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation.

Authors:  Kevin Paul; Maya Merabishvili; Ronen Hazan; Martin Christner; Uta Herden; Daniel Gelman; Leron Khalifa; Ortal Yerushalmy; Shunit Coppenhagen-Glazer; Theresa Harbauer; Sebastian Schulz-Jürgensen; Holger Rohde; Lutz Fischer; Saima Aslam; Christine Rohde; Ran Nir-Paz; Jean-Paul Pirnay; Dominique Singer; Ania Carolina Muntau
Journal:  Viruses       Date:  2021-09-07       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.